Buy One Get One free -Llimited Time Offer X
Celonib, a prescription drug, is manufactured in various forms such as Capsule. It is primarily used for the treatment of Chronic Myelogenous Leukemia. The alternative uses of Celonib have also been explained below.
The optimal dosage of Celonib is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Celonib have been listed ahead. Such side effects of Celonib normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Celonib is Severe for pregnant women and Moderate for women who are breastfeeding. In addition, Celonib's effects on the liver, heart and kidney are discussed below in the Celonib related warnings section.
The section on Celonib contraindications lists all such conditions.
Additionally, Celonib may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Celonib, it is important to know that it is not safe while driving, and is not habit-forming.
Celonib is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Celonib is used -
Severe
Moderate
Mild
Is the use of Celonib safe for pregnant women?
Celonib can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Celonib safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Celonib. Immediately discontinue Celonib if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Celonib on the Kidneys?
There may be some adverse effects on kidney after taking Celonib. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Celonib on the Liver?
Celonib is rarely harmful for the liver.
What is the effect of Celonib on the Heart?
The heart can be affected by Celonib. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Celonib should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Celonib unless your doctor advises you to do so -
Is this Celonib habit forming or addictive?
Forming a habit of Celonib has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Celonib you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Celonib should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Celonib is not used to treat mental disorders.
Interaction between Food and Celonib
It is safe to take Celonib with food.
Interaction between Alcohol and Celonib
Information about the interaction of Celonib and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869